Stock in Focus: Rajkumar Bafna, President-Finance of pharma company Akums Drugs and Pharmaceuticals, has resigned from his post. In the information given to the stock exchange on December 27, the company said that Bafna had mentioned the pollution level of Delhi in his resignation email.
According to regulatory disclosures, Bafna had submitted his resignation earlier this month. He will be formally relieved of his responsibilities on December 31, 2025. Akums Drugs has not yet announced a successor to Prince Bafana.
Pollution mentioned in resignation email
Email conversations attached with the documents deposited with the exchange show that in his resignation email sent to the company’s CFO Sumeet Sood on December 3, Bafna had cited Delhi’s pollution levels as the reason for stepping down. He had also requested to be relieved as soon as possible.
In response, the company accepted his resignation and said that in view of his health-related problems, it was not possible to convince him to continue in the post.
Joined Akums Drugs in August 2025
Rajkumar Bafna was holding the post of President-Finance in Akums Drugs since August 8, 2025. Prior to this, he has worked as Chief Financial Officer and Key Managerial Person in Heranba Industries Limited. He resigned with effect from June 30, 2025, after serving there for more than four years.
The company did not directly mention pollution as the reason.
Akums Drugs, counted among India’s largest pharmaceutical contract manufacturing companies, did not directly link the resignations to pollution in its exchange disclosure. As per the regulatory rules, the company has termed this as a health related decision.
Resignation amid severe pollution of Delhi
Bafna’s resignation comes at a time when air pollution in Delhi had reached extremely severe levels in late November and early December. During this period, the air quality in many areas of the capital remained in the ‘very poor’ to ‘severe’ category.
Vehicle smoke, industrial activities, dust from construction works and adverse weather conditions generally increase pollution in Delhi during winter season.
Over the past few years, there have been repeated public health warnings and emergency measures regarding Delhi’s deteriorating air quality. Medical experts have been warning that prolonged exposure to polluted air increases the risk of respiratory and heart diseases.
Status of shares of Akums Drugs
Shares of Akums Drugs had closed at Rs 449.95 on Friday with a gain of 0.82%. The stock is up 5.63% in the last 1 month. However, it has declined by 23.14% during the last 6 months. The stock has fallen 30.26% in 1 year. The market cap of the company is Rs 6.89 thousand crore.
Stocks to Watch: These 14 stocks will be in focus on Monday 29th December, you may get a chance to earn huge profits.
Disclaimer: The information provided here is being given for information only. It is important to mention here that investing in the market is subject to market risks. As an investor, always consult an expert before investing money. Moneycontrol never advises anyone to invest money here.